About Bioventrix
Bioventrix is a company based in San Ramon (United States) founded in 2003 by Lon Annest.. Bioventrix has raised $188.1 million across 26 funding rounds from investors including Andera Partners, Cormorant and Taglich Brothers. Bioventrix has completed 1 acquisition, including MateraCor. Bioventrix offers products and services including Heart Failure Treatment. Bioventrix operates in a competitive market with competitors including CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
- Headquarter San Ramon, United States
- Founders Lon Annest
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioventrix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$188.1 M (USD)
in 26 rounds
-
Latest Funding Round
$6.67 M (USD), Series E
Oct 10, 2024
-
Investors
Andera Partners
& 5 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioventrix
Bioventrix offers a comprehensive portfolio of products and services, including Heart Failure Treatment. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides innovative options for managing heart failure in patients.
Unlock access to complete
Unlock access to complete
Funding Insights of Bioventrix
Bioventrix has successfully raised a total of $188.1M across 26 strategic funding rounds. The most recent funding activity was a Series E round of $6.67 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 26
- Last Round Series E — $6.7M
-
First Round
First Round
(31 Aug 2004)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series E - Bioventrix | Valuation |
investors |
|
| Mar, 2024 | Amount | Series E - Bioventrix | Valuation |
investors |
|
| Apr, 2023 | Amount | Series E - Bioventrix | Valuation | Andera Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bioventrix
Bioventrix has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Andera Partners, Cormorant and Taglich Brothers. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Manages diversified investment portfolios across various asset classes.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioventrix
Bioventrix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MateraCor. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of tissue regenerative therapies for treating heart diseases
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Bioventrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioventrix Comparisons
Competitors of Bioventrix
Bioventrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable technology for hypertension and heart failure is developed.
|
|
| domain | founded_year | HQ Location |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for heart failure management are developed.
|
|
| domain | founded_year | HQ Location |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| domain | founded_year | HQ Location |
Implantable inter-atrial shunts are developed to treat chronic heart failure.
|
|
| domain | founded_year | HQ Location |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioventrix
Frequently Asked Questions about Bioventrix
When was Bioventrix founded?
Bioventrix was founded in 2003 and raised its 1st funding round 1 year after it was founded.
Where is Bioventrix located?
Bioventrix is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Who is the current CEO of Bioventrix?
David R is the current CEO of Bioventrix.
Is Bioventrix a funded company?
Bioventrix is a funded company, having raised a total of $188.1M across 26 funding rounds to date. The company's 1st funding round was a Series E of $48.5M, raised on Aug 31, 2004.
What does Bioventrix do?
BioVentrix was founded in 2003 in San Ramon, United States, within the medical device sector focused on cardiovascular health. Clinical solutions for heart failure patients are developed, including the PliCath HF, an epicardial catheter-based device for ventricular reshaping. Operations center on research and development, with the product not yet commercially available. Expertise is contributed by co-founders such as Lon Annest and co-CEO David R.
Who are the top competitors of Bioventrix?
Bioventrix's top competitors include Sequana Medical, CVRx and Adona Medical.
What products or services does Bioventrix offer?
Bioventrix offers Heart Failure Treatment.
How many acquisitions has Bioventrix made?
Bioventrix has made 1 acquisition, including MateraCor.
Who are Bioventrix's investors?
Bioventrix has 6 investors. Key investors include Andera Partners, Cormorant, Taglich Brothers, Squarepoint Capital, and Richmond Brothers.